Li Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li Xu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Qiang Zhang
Department of Clinical Laboratory, Department of Nephrology, the Second Hospital of Jilin University, Changchun, China
2 shared publicationsBing Li
Department of Clinical Laboratory, Department of Nephrology, the Second Hospital of Jilin University, Changchun, China
1 shared publicationHaifeng Wei
Diagnostic Medical Center, Jilin Province People's Hospital, Changchun, China
1 shared publicationHuiqiu Dong
Department of Radiology, The Second Hospital of Jilin University, Changchun, Jilin Province, China
1 shared publicationJianhua Fu
Diagnostic Medical Center, Jilin Province People's Hospital, Changchun, China
1 shared publicationJunsong Wang
Department of Ultrasound, The Second Hospital of Jilin University, Changchun, Jilin Province, China
1 shared publication
Latest Publications
- 1 March 2020
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 318 (3) , C640-C648
Zinc is essential for the transcription function of the PGC-1α/Nrf2 signaling pathway in human primary endometrial stromal cells
Zinc (Zn) has antioxidant effect in different types of organs and is closely associated with human health. The endometrial receptivity is one of the most important factors in the embryo implantation and development. However, the regulatory mechanism of Zn in endometrium tissue is still unclear. In the study, we found that plasma Zn level is significantly associated with female infertility, which is severely affecting female reproductive health. Primary endometrial stromal cells were isolated from female endometrium and cultured in laboratory. Zn chelator TPEN treatment reduced the expression of stem cell markers CD73, CD90 and CD105 and generated ROS in endometrial stromal cells. However, pre-treatment of Zn (zinc sulfate) is able to prevent TPEN-induced oxidative stress in vitro. By transcriptional profiling and GO analysis, we found that Zn increased the cellular pluripotency signaling and ECM-receptor interaction, but reduced the autophagy, endocytosis and nitrogen metabolism pathway. We further discovered the antioxidant function of Zn through PGC-1α/Nrf2 signaling pathway in the endometrial stromal cells. Zn-supplementation may open up an effective therapeutic approach for patients with oxidative stress-related endometrial diseases.
- 1 March 2020
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 318 (3) , C640-C648
Zinc is essential for the transcription function of the PGC-1α/Nrf2 signaling pathway in human primary endometrial stromal cells
Zinc (Zn) has antioxidant effect in different types of organs and is closely associated with human health. The endometrial receptivity is one of the most important factors in the embryo implantation and development. However, the regulatory mechanism of Zn in endometrium tissue is still unclear. In the study, we found that plasma Zn level is significantly associated with female infertility, which is severely affecting female reproductive health. Primary endometrial stromal cells were isolated from female endometrium and cultured in laboratory. Zn chelator TPEN treatment reduced the expression of stem cell markers CD73, CD90 and CD105 and generated ROS in endometrial stromal cells. However, pre-treatment of Zn (zinc sulfate) is able to prevent TPEN-induced oxidative stress in vitro. By transcriptional profiling and GO analysis, we found that Zn increased the cellular pluripotency signaling and ECM-receptor interaction, but reduced the autophagy, endocytosis and nitrogen metabolism pathway. We further discovered the antioxidant function of Zn through PGC-1α/Nrf2 signaling pathway in the endometrial stromal cells. Zn-supplementation may open up an effective therapeutic approach for patients with oxidative stress-related endometrial diseases.
- 10 November 2018
- Published by Wiley in IUBMB Life
- Vol. 71 (2) , 277-282
Circulating Oxidized Low‐Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease
This study aimed to detect the circulating oxidized low‐density lipoprotein (ox‐LDL) levels of controls and patients with stable angina pectoris (SAP), unstable angina pectoris (UAP), and acute myocardial infarction (AMI) and also to investigate the correlation with the severity of coronary heart disease (CHD). Plasma levels of circulating ox‐LDL‐4E6, malondialdehyde (MDA), high‐sensitivity C‐reactive protein (hs‐CRP), total cholesterol, high‐density lipoprotein cholesterol, LDL cholesterol, apoprotein A, apoprotein B, and lipoprotein (a) (Lp(a)) were measured in 99 participants who underwent coronary angiography. The plasma ox‐LDL level was significantly higher in patients with CHD than in controls (P = 0.000). However, it was lower in the UAP and AMI groups than in the SAP group (P = 0.000). The lipid peroxide level (MDA) showed a significant difference among all groups (P = 0.000). It increased significantly in patients with CHD. The Lp(a) and hs‐CRP levels were significantly higher in patients with CHD (P = 0.000 and 0.000, respectively). No difference in Lp(a) was found among the SAP, UAP, and AMI groups (P = 0.296). In patients with CHD, the plasma ox‐LDL correlated negatively with hs‐CRP (P = 0.011), and serum MDA correlated positively with hs‐CRP (P = 0.004). The plasma ox‐LDL could be used as a strong risk factor for the early stage but not the advanced stage of CHD. Hs‐CRP may bound and transfer ox‐LDL to macrophages. © 2018 IUBMB Life, 71(1):277–282, 2019
- 10 November 2018
- Published by Wiley in IUBMB Life
- Vol. 71 (2) , 277-282
Circulating Oxidized Low‐Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease
This study aimed to detect the circulating oxidized low‐density lipoprotein (ox‐LDL) levels of controls and patients with stable angina pectoris (SAP), unstable angina pectoris (UAP), and acute myocardial infarction (AMI) and also to investigate the correlation with the severity of coronary heart disease (CHD). Plasma levels of circulating ox‐LDL‐4E6, malondialdehyde (MDA), high‐sensitivity C‐reactive protein (hs‐CRP), total cholesterol, high‐density lipoprotein cholesterol, LDL cholesterol, apoprotein A, apoprotein B, and lipoprotein (a) (Lp(a)) were measured in 99 participants who underwent coronary angiography. The plasma ox‐LDL level was significantly higher in patients with CHD than in controls (P = 0.000). However, it was lower in the UAP and AMI groups than in the SAP group (P = 0.000). The lipid peroxide level (MDA) showed a significant difference among all groups (P = 0.000). It increased significantly in patients with CHD. The Lp(a) and hs‐CRP levels were significantly higher in patients with CHD (P = 0.000 and 0.000, respectively). No difference in Lp(a) was found among the SAP, UAP, and AMI groups (P = 0.296). In patients with CHD, the plasma ox‐LDL correlated negatively with hs‐CRP (P = 0.011), and serum MDA correlated positively with hs‐CRP (P = 0.004). The plasma ox‐LDL could be used as a strong risk factor for the early stage but not the advanced stage of CHD. Hs‐CRP may bound and transfer ox‐LDL to macrophages. © 2018 IUBMB Life, 71(1):277–282, 2019